Critical Properties in Photoemmision Spectra for One Dimensional Orbitally Degenerate Mott Insulator

Critical properties in photoemission spectra for the one-dimensional Mott insulator with orbital degeneracy are studied by exploiting the integrable {\it t-J} model, which is a supersymmetric generalization of the SU($n$) degenerate spin model. We discuss the critical properties for the holon dispersion as well as the spinon dispersions, by applying the conformal field theory analysis to the exact finite-size energy spectrum. We study the effect of orbital-splitting on the spectra by evaluating the momentum-dependent critical exponents.Comment: 8 pages, REVTeX, 2 figures(available upon request), accepted for publication in JPSJ 68 (1999) No.

Critical Properties of Spectral Functions for the 1D Anisotropic t-J Models with an Energy Gap

We exactly calculate the momentum-dependent critical exponents for spectral functions in the one-dimensional anisotropic t-J models with a gap either in the spin or charge excitation spectrum. Our approach is based on the Bethe ansatz technique combined with finite-size scaling techniques in conformal field theory. It is found that the spectral functions show a power-law singularity, which occurs at frequencies determined by the dispersion of a massive spin (or charge) excitation.We discuss how the nontrivial contribution of a massive excitation controls the singular behavior in optical response functions.Comment: 4 pages, REVTeX, 2 figures(available upon request), accepted for publication in JPSJ 66 (1997) No.

Boron-rich, cytocompatible block copolymer nanoparticles by polymerization-induced self-assembly

Core-shell nanoparticles (NPs) with a boron-rich core were synthesized by RAFT-mediated polymerization-induced self-assembly using a new methacrylic boronate ester monomer. Under specific conditions, sub-100 nm spherical NPs could be obtained at high conversions by either emulsion or dispersion RAFT polymerization using poly(oligo(ethylene glycol) methacrylate) (POEGMA) dithiobenozate-based chain transfer agents. Phenylboronic acid surface-functionalized NPs were obtained using a telechelic POEGMA. Primary data on biocompatibility is provided and suggests suitability as boron delivery agent for boron neutron capture therapy

Properties of a Luttinger Liquid with Boundaries at Finite Temperature and Size

We use bosonization methods to calculate the exact finite-temperature single-electron Green's function of a spinful Luttinger liquid confined by open boundaries. The corresponding local spectral density is constructed and analyzed in detail. The interplay between boundary, finite-size and thermal effects are shown to dramatically influence the low-energy properties of the system. In particular, the well-known zero-temperature critical behavior in the bulk always crosses over to a boundary dominated regime in the vicinity of the Fermi level. Thermal fluctuations cause an enhanced depletion of spectral weight for small energies E, with the spectral density scaling as E^2 for E much less than the temperature. Consequences for photoemission experiments are discussed.Comment: 18 pages in revtex format including 5 embedded figures (using epsf). The latest complete postscript file is available from http://fy.chalmers.se/~eggert/papers/longlutt.ps or by request from [email protected]. To appear in Phys. Rev. B (Dec. 1997

Spectral functions of the 1D Hubbard model in the U -> \infty limit: How to use the factorized wave-function

We give the details of the calculation of the spectral functions of the 1D Hubbard model using the spin-charge factorized wave-function for several versions of the U -> +\infty limit. The spectral functions are expressed as a convolution of charge and spin dynamical correlation functions. A procedure to evaluate these correlation functions very accurately for large systems is developed, and analytical results are presented for the low energy region. These results are fully consistent with the conformal field theory. We also propose a direct method of extracting the exponents from the matrix elements in more general cases.Comment: 15 pages,7 eps figures, RevTeX, needs epsf and multico

Supporting positive dimensions of health, challenges in mental health care

This paper will explore two contrasting paradigms in mental health care and their relationship to evidence-based practice. The biomedical perspective of pathogenesis and the health perspective of salotogenesis are two major diverse views in mental health care. Positive dimensions of health are traditionally viewed as software not suitable for statistical analysis, while absence of symptoms of disease are regarded as measurable and suitable for statistical analysis and appropriate as a foundation of evidence-based practice. If the main goal of mental health care is to enhance subjectively experienced health among patients, it will not be sufficient to evaluate absence of symptoms of disease as a measure of quality of care. The discussion focuses on the paradox of evidence-based absence of illness and disease versus subjectively experienced health and well-being as criterions of quality of care in mental health care

Critical Josephson Current in a Model Pb/YBa_2Cu_3O_7 Junction

In this article we consider a simple model for a c--axis Pb/YBa_2Cu_3O_{7-\delta} Josephson junction. The observation of a nonzero current in such a junction by Sun et al. [A. G. Sun, D. A. Gajewski, M. B. Maple, R. C. Dynes, Phys. Rev. Lett. 72, 2267 (1994)] has been taken as evidence against d--wave superconductivity in YBa_2Cu_3O_{7-\delta}. We suggest, however, that the pairing interaction in the CuO_2 planes may well be d--wave but that the CuO chains destroy the tetragonal symmetry of the system. We examine two ways in which this happens. In a simple model of an incoherent junction, the chains distort the superconducting condensate away from d_{x^2-y^2} symmetry. In a specular junction the chains destroy the tetragonal symmetry of the tunneling matrix element. In either case, the loss of tetragonal symmetry results in a finite Josephson current. Our calculated values of the critical current for specular junctions are in good agreement with the results of Sun and co-workers.Comment: Latex File, 21 pages, 6 figures in uuencoded postscript, In Press (Phys. Rev. B

Spatial Pd-L1, Immune-Cell Microenvironment, and Genomic Copy-Number Alteration Patterns and Drivers of Invasive-Disease Transition in Prospective Oral Precancer Cohort

BACKGROUND: Studies of the immune landscape led to breakthrough trials of programmed death-1 (PD-1) inhibitors for recurrent/metastatic head and neck squamous cell carcinoma therapy. This study investigated the timing, influence of somatic copy-number alterations (SCNAs), and clinical implications of PD-L1 and immune-cell patterns in oral precancer (OPC). METHODS: The authors evaluated spatial CD3, CD3/8, and CD68 density (cells/mm RESULTS: Epithelial, but not CD68 immune-cell, PD-L1 expression was detected in 28% of OPCs, correlated with immune-cell infiltration, 9p21.3 loss of heterozygosity (LOH), and inferior oral cancer-free survival (OCFS), notably in OPCs with low CD3/8 cell density, dysplasia, and/or 9p21.3 LOH. High CD3/8 cell density in dysplastic lesions predicted better OCFS and eliminated the excess risk associated with prior oral cancer and dysplasia. PD-L1 and CD3/8 patterns revealed inferior OCFS in PD-L1 high intrinsic induction and dysplastic immune-cold subgroups. CONCLUSION: This report provides spatial insight into the immune landscape and drivers of OPCs, and a publicly available immunogenomic data set for future precancer interrogation. The data suggest that 9p21.3 LOH triggers an immune-hot inflammatory phenotype; whereas increased 9p deletion size encompassing CD274 at 9p24.1 may contribute to CD3/8 and PD-L1 depletion during invasive transition. The inferior OCFS in PD-L1-high, immune-cold OPCs support the development of T-cell recruitment strategies

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

PurposeHigh-dose pegylated interferon α-2b (peginterferon α-2b) significantly decreased disease recurrence in patients with resected stage III melanoma in a clinical study. We investigated the pharmacokinetics (PK) and safety of high-dose peginterferon α-2b in patients with high-risk melanoma.MethodsFor PK analysis, 32 patients received peginterferon α-2b 6 μg/(kg week) subcutaneously for 8 weeks (induction) then 3 μg/(kg week) for 4 weeks (maintenance). PK profiles were determined at weeks 1, 8, and 12. Exposure-response relationships between peginterferon α-2b and absolute neutrophil count (ANC) and alanine aminotransferase (ALT) level were also studied.ResultsPeginterferon α-2b was well-absorbed following SC administration, with a median T (max) of 24 h. Mean half-life estimates ranged from 43 to 51 h. The accumulation factor was 1.69 after induction therapy. PK parameters showed moderate interpatient variability. PK profiles were described by a one-compartmental model with first-order absorption and first-order elimination. Toxicity was profiled and was acceptable; observed side effects were similar to those previously described. Dose reduction produced proportional decreases in exposure and predictable effects on ANC in an Imax model; however, a PK/pharmacodynamic (PK/PD) relationship between peginterferon α-2b and ALT could not be established with high precision.ConclusionsPeginterferon α-2b was well-absorbed and sustained exposure to peginterferon α-2b was achieved with the doses tested. These data confirm and extend previous PK observations of peginterferon α-2b in melanoma and solid tumors. Our PK/PD model of exposure and ANC effect provides useful information for prediction of peginterferon α-2b-related hematologic toxicity

Interleukin-6 Induces Gr-1+CD11b+ Myeloid Cells to Suppress CD8+ T Cell-Mediated Liver Injury in Mice

Agonist antibodies against CD137 (4-1BB) on T lymphocytes are used to increase host anti-tumor immunity, but often leading to severe liver injury in treated mice or in patients during clinical trials. Interleukin-6 (IL-6) has been reported to protect hepatocyte death, but the role of IL-6 in protecting chronic T cell-induced liver diseases is not clearly defined due to lack of relevant animal models. We aimed to define the role of IL-6 in CD8+ T cell-mediated liver injury induced by a CD137 agonistic mAb (clone 2A) in mice.We expressed IL-6 in the liver by hydrodynamic gene delivery in mice treated with 2A or control mAb and studied how IL-6 treatment affected host immunity and T cell-mediated liver injury. We found that ectopic IL-6 expression in the liver elevated intrahepatic leukocyte infiltration but prevented CD8+ T cell-mediated liver injury. In IL-6 treated mice, CD8+ T cells proliferation and IFN-γ expression were inhibited in the liver. We discovered that IL-6 increased accumulation of Gr-1+CD11b+ myeloid derived suppressor cells (MDSCs) in the liver and spleen. These MDSCs had the ability to inhibit T cells proliferation and activation. Finally, we showed that the MDSCs were sufficient and essential for IL-6-mediated protection of anti-CD137 mAb-induced liver injury.We concluded that IL-6 induced Gr-1+CD11b+ MDSCs in the liver to inhibit T cell-mediated liver injury. The findings have defined a novel mechanism of IL-6 in protecting liver from CD8+ T cell-mediated injury